课题基金 / 基金详情

Regulation of Tumor necrosis factor Receptor-Associated Factor 1 (TRAF1) by Protein Kinase N1 (PKN1): implications for lymphoma

Regulation of Tumor necrosis factor Receptor-Associated Factor 1 (TRAF1) by Protein Kinase N1 (PKN1): implications for lymphoma
蛋白激酶 N1 (PKN1) 对肿瘤坏死因子受体相关因子 1 (TRAF1) 的调节:对淋巴瘤的影响
批准号:
349862
负责人:
Ting Kenneth K
金额:
$1.27万
依托单位:
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-12-01 至 2016-12-01

项目摘要

项目成果

Ting Kenneth K的其他基金

相关文献

中文摘要
翻译
淋巴瘤是世界范围内第十大常见的癌症原因,是白色血细胞(也称为淋巴细胞)的癌性形式。虽然有很多治疗方案,但5年生存率仍只有67%,癌症需要新的治疗方法
英文摘要
Lymphomas, the 10th most common cause of cancer worldwide, are cancerous forms of white blood cells, also known as lymphocytes. Although there are many treatment options, the 5-year survival rate is still only 67%, and new treatments are needed for cancer
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lipid loading of macrophages suppresses LPS-induced inflammatory gene expression by negatively regulating HIF1a-dependent glycolysis
Regulation of TRAF1 by Protein Kinase N1 (PKN1): implications for human disease
  • 批准号:
    348293
  • 项目类别:
    Studentship Programs
  • 资助金额:
    $0.36万
  • 财政年份:
    2016
  • 负责人:
    Ting Kenneth K
  • 依托单位: